Clinical Trial Matcher

NCT06297980

Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes

Recruiting · Not Applicable · University of Colorado, Denver · registry updated 2026-06-16

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

The objectives of this study are to examine how sex hormones (use of hormonal birth control, menstrual cycle phase) impact glycemic control among women with type 1 diabetes (T1D), and to test adjustments to insulin dosing and food intake to ameliorate cycle-related glycemic variability. A secondary aim is to examine how the menstrual cycle and use of hormonal birth control impact patient-reported outcomes and glycemic responses to physical activity.

Inclusion

  • Women 18-45 who have had type 1 diabetes for at least 12 months
  • Premenopausal with either menstrual cycles or currently using oral contraceptives

Exclusion

  • Women who are postmenopausal, pregnant, trying to become pregnant, or have had a hysterectomy

Open NCT06297980 on ClinicalTrials.govAll conditions